• ViGeneron and WuXi Advanced Therapies Enter Partnership contractpharma
    December 03, 2020
    ​ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. have announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.
  • WuXi Launches CAR-T Cell Therapy Platform contractpharma
    May 19, 2020
    Will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patients.
PharmaSources Customer Service